Data protection Impressum

Financing

Top Stories Western Switzerland

Business environment

Top Stories from Western Switzerland (August 2026)

31 August 2026

Addex Therapeutics, the Geneva-based clinical-stage biotech developing small-molecule allosteric modulators for neurological disorders, has raised gross proceeds of USD 2.8 million through its at-the-market program.

Addex Therapeutics extends its cash runway into the fourth quarter of 2027

31 August 2026

The Foundation for Innovation and Technology has awarded a CHF 200,000 Digital Growth loan to WasteFlow, CHF 50,000 Digital Seed loans to DOCumenter and Nextrainers, and a CHF 20,000 Digital Grant to RiveLock.

FIT supports four Vaud start-ups through its Digital programs

31 August 2026

Adaptyv Biosystems has closed a USD 40 million Series A round to expand the automated laboratory it operates for the rapid experimental validation of newly designed proteins.

Adaptyv raises USD 40 million for its automated protein lab

31 August 2026

Bewe, a University of Fribourg spin-off developing a neuroscience-based digital intervention for unhealthy food cravings, has been awarded Biopôle's Pre-Clinical Top-Up, a CHF 250,000 convertible loan supporting start-ups facing high clinical validation costs.

Bewe awarded the Biopôle Pre-Clinical Top-Up for its digital therapy against food cravings

20 August 2026

Top Stories Western Switzerland

Business environment

Top Stories from Western Switzerland (July 2026)

3 August 2026

AB2 Bio has received a USD 30 million payment after Japanese pharmaceutical company Nippon Shinyaku exercised its option to commercialize Tadekinig alfa in the United States, with up to USD 600 million in further milestone and royalty payments.

AB2 Bio receives USD 30 million as Nippon Shinyaku takes up US rights

3 August 2026

Hilo closes a USD 19 million Series B extension to fuel its US expansion

3 August 2026

Actival, a CSEM spin-off based in Neuchâtel, has been awarded a CHF 1.4 million grant from Innosuisse to accelerate the development and market launch of its patented Active Splints, a new generation of dental aligners that dispense antibacterial fluid and fluoride.

Actival secures a CHF 1.4 million Innosuisse grant for its smart dental aligners

3 August 2026

MoleSense and Impli, both based at the Biopôle life sciences campus, have been selected by Germany's Federal Agency for Breakthrough Innovation to develop biosensors capable of continuously measuring at least four hormones over seven days.

MoleSense and Impli selected for the SPRIND Challenge on continuous hormone monitoring

3 August 2026

1 2 3 4 5 … 33